Detalles de la búsqueda
1.
A phase I study of the P-glycoprotein antagonist tariquidar in combination with vinorelbine.
Clin Cancer Res
; 15(10): 3574-82, 2009 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19417029
2.
Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days.
J Clin Oncol
; 21(9): 1866-73, 2003 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12721265
3.
A phase I/II study of infusional vinblastine with the P-glycoprotein antagonist valspodar (PSC 833) in renal cell carcinoma.
Clin Cancer Res
; 10(14): 4724-33, 2004 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-15269145
4.
Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms.
Clin Cancer Res
; 8(3): 718-28, 2002 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-11895901
5.
Design and methods for a pilot randomized clinical trial involving exercise and behavioral activation to treat comorbid type 2 diabetes and major depressive disorder.
Ment Health Phys Act
; 4(1): 13-21, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21765864
6.
A Phase I clinical trial of ixabepilone (BMS-247550), an epothilone B analog, administered intravenously on a daily schedule for 3 days.
Cancer
; 103(9): 1932-8, 2005 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15800893
7.
A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Cancer
; 94(9): 2333-43, 2002 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-12015757
Resultados
1 -
7
de 7
1
Próxima >
>>